These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25197357)

  • 21. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
    Lin L; Piao J; Gao W; Piao Y; Jin G; Ma Y; Li J; Lin Z
    BMC Cancer; 2013 Jul; 13():366. PubMed ID: 23902796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc-finger protein X-linked is a novel predictor of prognosis in patients with colorectal cancer.
    Yan X; Yan L; Su Z; Zhu Q; Liu S; Jin Z; Wang Y
    Int J Clin Exp Pathol; 2014; 7(6):3150-7. PubMed ID: 25031734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival.
    Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Sulik M; Kmiec Z
    Oncol Rep; 2017 Jul; 38(1):201-210. PubMed ID: 28586030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.
    Yuan XS; Zhang Y; Guan XY; Dong B; Zhao M; Mao LL; Lu YY; Tian XY; Hao CY
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1211-20. PubMed ID: 23576022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer.
    Ma Z; Lian J; Yang M; Wuyang J; Zhao C; Chen W; Liu C; Zhao Q; Lou C; Han J; Zhang Y
    Pathol Res Pract; 2019 Jun; 215(6):152383. PubMed ID: 30890279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of MSP58 in human colorectal cancer and its correlation with prognosis.
    Shi H; Li SJ; Zhang B; Liu HL; Chen CS
    Med Oncol; 2012 Dec; 29(5):3136-42. PubMed ID: 22773039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Keratin 7 expression in lymph node metastases but not in the primary tumour correlates with distant metastases and poor prognosis in colon carcinoma.
    Czapiewski P; Bobowicz M; Pęksa R; Skrzypski M; Gorczyński A; Szczepańska-Michalska K; Korwat A; Jankowski M; Zegarski W; Szulgo-Paczkowska A; Polec T; Piątek M; Skokowski J; Haybaeck J; Żaczek A; Biernat W
    Pol J Pathol; 2016; 67(3):228-234. PubMed ID: 28155971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
    BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival.
    Liu Y; Zhou J; Zhang C; Fu W; Xiao X; Ruan S; Zhang Y; Luo X; Tang M
    Int J Clin Exp Pathol; 2014; 7(3):969-77. PubMed ID: 24696714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
    Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
    Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
    Xi HQ; Zhao P
    J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
    Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
    Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
    Pak MG; Koh HJ; Roh MS
    Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
    Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
    Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer.
    Yang B; Cao L; Liu J; Xu Y; Milne G; Chan W; Heys SD; McCaig CD; Pu J
    Cancer; 2015 May; 121(10):1570-80. PubMed ID: 25603912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
    Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
    Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased MALL expression negatively impacts colorectal cancer patient survival.
    Wang X; Fan J; Yu F; Cui F; Sun X; Zhong L; Yan D; Zhou C; Deng G; Wang B; Qi X; Wang S; Qu L; Deng B; Pan M; Chen J; Wang Y; Song G; Tang H; Zhou Z; Peng Z
    Oncotarget; 2016 Apr; 7(16):22911-27. PubMed ID: 26992238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.